Cite
HARVARD Citation
Arihiro, S. et al. (2016). Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study. International journal of stroke. 11 (5), pp. 565-574. [Online].